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The a-helix in troponin I (TnI) at the interface with troponin T (TnT) is a highly conserved structure.
A point mutation in this region, A116G, was found in human cardiac TnI in a case of cardiomyopa-
thy. An adjacent dominantly negative mutation found in turkey cardiac TnI (R111C, equivalent to
K117C in human and K118C in mouse) decreased diastolic function and blunted beta-adrenergic
response in transgenic mice. To investigate the functional importance of the TnI–TnT interface
and pathological impact of the cardiac TnI mutations, we engineered K118C and A117G mutations
in mouse cardiac TnI for functional studies. Despite their adjacent locations, A117G substitution
results in faster mobility of cardiac TnI in SDS–PAGE whereas K118C decreases gel mobility, indicat-
ing signiﬁcant and distinct changes in overall protein conformation. Consistently, monoclonal anti-
body epitope analysis demonstrated distinct local and remote conformational alterations in the two
mutant proteins. Protein binding assays showed that K118C, but not A117G, decreased the relative
binding afﬁnity of cardiac TnI for TnT. K118C mutation decreased binding afﬁnity for troponin C in a
Ca2+-dependent manner, whereas A117G had a similar but less profound effect. Protein kinase A
phosphorylation or truncation to remove the cardiac speciﬁc N-terminal extension of cardiac TnI
resulted in similar conformational changes in the region interfacing with TnT and minimized the
functional impacts of the mutations. The data demonstrate potent conformational and functional
impacts of the TnT-interfacing helix in TnI and suggest a role of the N-terminal extension of cardiac
TnI in modulating TnI–TnT interface functions.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction [4]. This segment of TnI is a relatively rigid structure [5] withThe troponin complex plays a central role in the Ca2+ regulation
of cardiac and skeletal muscle contraction. The binding of Ca2+ to
troponin subunit C (TnC) induces a series of conformational
changes in troponin complex and sarcomeric actin thin ﬁlament
to activate cross bridge cycling between myosin and actin and
muscle contraction [1]. Troponin I (TnI) is the inhibitory subunit
of troponin [2]. An a-helix in TnI (amino acids 90–135 in human
cardiac TnI) [3] forms a coiled coil interface with troponin T
(TnT) (Fig. 1A), the tropomyosin anchoring subunit of troponinamino acid sequence highly conserved in muscle type-speciﬁc
TnI isoforms and across vertebrate species [6–8].
Very few pathogenic mutations have been found in this highly
conserved region of cardiac TnI. A single amino acid substitution,
A116G, was reported in association with cardiomyopathy [9]. An
adjacent single amino acid substitution was found in the TnT-
interfacing helix of wild turkey cardiac TnI (R111C, as the position
equivalent to K117 in human cardiac TnI) in concurrence with an
abnormally spliced myopathic cardiac TnT [6]. The substitution
of Arg111 with Cys in turkey cardiac TnI reduced binding afﬁnity
for TnT, compensating for the effect of the abnormally spliced car-
diac TnT. Overexpression of the corresponding mutation (K118C)
in mouse cardiac TnI (McTnIK118C) reduced diastolic function and
blunted b-adrenergic response in transgenic mouse hearts [10].
Isolated adult cardiomyocytes from McTnIK118C transgenic mice
exhibited lower contractile amplitude and slower velocities of
shortening and re-lengthening than wild type controls with lower
responses to b-adrenergic stimulation [11]. In the mean time,
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icantly longer than cells isolated from age- and sex-matched wild
type mice [11]. Such early remodeling of McTnIK118C cardiomyo-
cytes prior to the development of clinical heart failure indicates
potent effects of K118C mutation on myocardial remodeling. These
two mutations with dominantly negative impacts on cardiac mus-
cle function indicate the functional importance of the TnI–TnT
interface in the troponin complex.
Different from slow and fast skeletal muscle TnI, cardiac TnI has
an 30 amino acids N-terminal extension [2,12,13]. An adult
heart-speciﬁc regulatory structure, the N-terminal extension con-
tains b-adrenergic activated protein kinase A (PKA) phosphoryla-
tion sites Ser23/S24 [14]. Phosphorylation of Ser23/S24 modulates
the function of cardiac TnI [12,15–17], involving long-range con-
formational modulations [18]. The N-terminal extension of cardiac
TnI is also regulated by a selective deletion via limited, proteolysis,
occurring in cardiac adaptation to hemodynamic stress and b-
adrenergic deﬁciency [19–21]. PKA phosphorylation at Ser23/S24
in the N-terminal extension or truncation of the entire N-terminal
extension lowers myoﬁlament Ca2+ sensitivity and facilitates car-
diac muscle relaxation. Their similar and non-additive regulatory
effects [22] implicate a common down-stream mechanism for
the N-terminal extension to regulate the function of cTnI [22,23].
Consistent with this hypothesis, PKA phosphorylation and N-
terminal truncation result in similar conformational modulations
in cardiac TnI in the region interfacing with TnT and produce sim-
ilar effects on the binding afﬁnity of cardiac TnI for TnT and TnC
[18]. Supporting the structural importance and sensitivity of the
TnT interface of TnI, mutations in the C-terminal end segment of
cardiac TnI (R193H and R205H), which cause restrictive cardiomy-
opathy, also result in conformational changes in this region [24].Fig. 1. Cardiac TnI mutations in the helix interfacing with TnT. (A) The residues A116 (A1
the PKA phosphorylation sites Ser23/24 in the N-terminal extension, and the epitopes for
troponin complex (redrawn from published data) [3]. (B) The linear map of mouse car
occurring cleavage site that selectively removes the cardiac-speciﬁc N-terminal extension
mAbs 4H6 and 4B7, and the A117G and K118C mutations.To further understand the function and regulation of the TnT
interface structure of TnI, here we characterized the conforma-
tional and functional effects of A117G and K118C mutations in
intact as well as in N-terminal truncated mouse cardiac TnI. The
results showed that the two adjacent TnI–TnT interface mutations
produced distinct conformational and functional changes in car-
diac TnI. The effects of N-terminal phosphorylation and truncation
on the function of the mutant cardiac TnI were investigated for
regulatory and compensatory impacts. The data demonstrate the
critical role of the TnI–TnT interface in the regulation of muscle
contraction and cardiac function.
2. Results
2.1. A117G and K118C mutations produced opposite effects on the
mobility of cardiac TnI in SDS–PAGE
Wild type and mutant mouse cardiac TnI protein, intact or with
the N-terminal extension truncated (Fig. 1B), were successfully
expressed in Escherichia coli and puriﬁed (Fig. 2A and B). In addi-
tion to sequencing veriﬁcation of the cDNA constructs, Western
blots using mAb TnI-1 against a conserved C-terminal epitope of
TnI conﬁrmed the authenticity of recombinant proteins (Fig. 2A
and B).
A striking ﬁnding is that McTnIA117G exhibits faster gel mobility
than that of wild type mouse cardiac TnI in SDS–PAGE, whereas
McTnIK118C exhibits slower SDS–gel mobility than that of wild type
mouse cardiac TnI (Fig. 2A). Implication of the results is twofold:
First, these single amino acid substitutions in the TnT interface
helix of cardiac TnI corresponding to minimum changes in molec-
ular mass (Mr for McTnI = 24,258, McTnIA117G = 24,245 and17 in mouse) and K117 (K118 in mouse) in human cardiac TnI at the TnT interface,
mAbs 4H6 and 4B7 are highlighted in the partial crystal structure of human cardiac
diac TnI illustrates the locations of PKA phosphorylation sites Ser23/24, a naturally
to modify contractility, the TnT and TnC binding regions, the epitopes recognized by
Fig. 2. A117G and K118C mutations have opposite effects on the mobility of cardiac TnI in SDS–PAGE. (A) The SDS–PAGE and mAb TnI-1 Western blots showed that A117G
mutation increased and K118C mutation decreased the gel mobility of intact mouse cardiac TnI in SDS–PAGE as compared with wild type control. There was a contaminant
protein in the McTnIK118C preparation (pointed by the arrowhead), which however, did not affect the coating of McTnIK118C to ELISA plate for conformational and protein
binding studies. (B) SDS–PAGE and mAb TnI-1 Western blots showed that removal of the N-terminal extension did not have qualitative effect on this feature of the mutations.
(C) Pro-Q Diamond and Coomassie Blue staining of McTnI, McTnIA117G and McTnIK118C showed effective phosphorylation after PKA treatment. The gel mobility of McTnI,
McTnIA117G and McTnIK118C decreased slightly upon phosphorylation, implicating an effect on the overall molecular conformation and the binding of SDS [29]. Different from
the molecular weight makers used in (A) and (B), PeppermintStick phosphoprotein molecular weight marker was used as a control in Panel C.
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tural changes readily detectable as mobility changes in SDS–gel;
and second, A117G and K118C mutations produce distinct struc-
tural changes leading to the opposite effects on SDS–gel mobility
independent of the trivial changes in molecular mass (Fig. 2A). In
comparison with wild type cardiac TnI, the faster gel mobility of
McTnIA117G may indicate a more compact or more compliant over-
all molecular conformation whereas McTnIK118C may have pro-
duced a more open or more rigid conformation.
N-terminal truncation that is known to result in long-range
conformational modulations in cardiac TnI [18] did not change
the gel mobility features of McTnIA117G and McTnIK118C (Fig. 2B).
Therefore, the effects of the two point mutations at the TnT-bind-
ing interface on the molecular conformation of cardiac TnI appear
to be dominant traits.
PKA catalyzed phosphorylation at Ser23/24 in the N-terminal
extension was at similar extents in McTnIA117G, McTnIK118C, andwild type McTnI as visualized by Pro-Q Diamond staining
(Fig. 2C). The results also showed that PKA phosphorylation
slightly decreased the mobility of McTnI, McTnIA117G and
McTnIK118C, consistent with the conformational modulation role
of the N-terminal extension [18].
2.2. Conformational effects of A117G and K118C mutations on
functional sites of cardiac TnI
ELISA epitope analysis using two anti-cardiac TnI mAb probes,
4B7 that recognizes an epitope in the helix interfacing with TnT
and 4H6 that recognizes an epitope in the TnC-binding helix 1
(Fig. 1A), identiﬁed local and remote conformational changes
resulting from A117G and K118C mutations of cardiac TnI.
The results in Fig. 3 showed that mAb 4B7 detected a statisti-
cally signiﬁcant change in the local conformation of the TnT-inter-
facing helix in McTnIA117G but not McTnIK118C. The results
Fig. 4. Mutation A117G, but not K118C, of cardiac TnI in the TnT interface alters the
conformation of the TnC-binding helix 1. ELISA epitope analysis using mAb 4H6
recognizing an epitope at the TnC binding helix 1 in cardiac TnI detected a
signiﬁcant conformational change caused by the A117G mutation (⁄⁄⁄P < 0.00001),
but the adjacent K118C mutation did not have signiﬁcant effect. Statistical analyses
were done using Fisher test in Two Way ANOVA with Origin Pro 8 software.
Fig. 5. Mutation K118C, but not A117G, in the TnT interface of cardiac TnI decreases
the binding afﬁnity for TnT. Protein binding assay showed that mutation K118C, but
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each other in an a-helix (Fig. 1A), they had rather distinct effects
on the local conformation.
Monoclonal antibody 4H6 detected a remote conformational
change in the TnC-binding helix 1 of cardiac TnI resulting from
the A117G mutation (Fig. 4). In contrast, the adjacent K118C muta-
tion did not convey such remote conformational change (Fig. 4).
The results further demonstrate that the two mutations also had
distinct remote conformational effects.
2.3. Mutation K118C, but not A117G, lowers the relative binding
afﬁnity of cardiac TnI for TnT
Solid phase protein binding assay [25] revealed that the K118C
mutation in the TnT interface helix resulted in a statistically signif-
icant decrease in the relative binding afﬁnity of cardiac TnI for TnT
(Fig. 5). On the other hand, the adjacent mutation A117G did not
signiﬁcantly alter the binding afﬁnity for TnT (Fig. 5).
2.4. A117G and K118C mutations both decrease the relative binding
afﬁnity of cardiac TnI for TnC at pCa 4
ELISA solid phase protein binding assay demonstrated that at
pCa 9, TnC binds TnI with low afﬁnity (Fig. 6A), consistent with
that shown in previous studies in solution or using afﬁnity chro-
matography [26,27]. Neither A117G nor K118C mutation had
detectable effect on the binding afﬁnity of cardiac TnI for TnC at
pCa 9 (Fig. 6A).
At pCa 4, the binding afﬁnity of TnC for TnI was signiﬁcantly
higher than that at pCa 9 (Fig. 6B), also consistent with previous
studies using traditional protein binding assays [27]. The K118C
mutation signiﬁcantly decreased the relative binding afﬁnity of
cardiac TnI for TnC at pCa 4 (Fig. 6B). The adjacent mutation
A117G also produced a detectable decrease in the relative binding
afﬁnity for TnC at pCa 4, although much less than that caused by
K118C (Fig. 6B).
2.5. Effects of N-terminal modiﬁcations on relative binding afﬁnity of
the mutant cardiac TnI for TnT
The N-terminal extension of cardiac TnI is an adult heart-spe-
ciﬁc regulatory structure [28] that is known to ﬁne-tune the func-Fig. 3. A117G and K118C mutations result in local conformational changes. ELISA
epitope analysis using mAb 4B7 recognizing an epitope at the TnT interfacing helix
of cardiac TnI detected a signiﬁcant conformational change produced by the A117G
mutation (⁄⁄⁄P < 0.00001), where as the adjacent K118C mutation had no signiﬁcant
effect. Statistical analyses were done using Fisher test in Two Way ANOVA with
Origin Pro 8 software.
not A117G, caused a decrease in the binding afﬁnity of cardiac TnI for TnT (⁄P < 0.01
as comparing data points in the binding curves corresponding to TnT concentra-
tions from 8  109 M to 1  106 M). Statistical analyses were done using Fisher
test in Two Way ANOVA with Origin Pro 8 software.tion of troponin via phosphorylation of Ser23/S24 by PKA [12,15–17]
and truncation by limited proteolysis [19,21,22]. ELISA solid phase
protein binding assay showed that PKA phosphorylation of Ser23/24
in the N-terminal segment and deletion of the entire N-terminal
segment of wild type cardiac TnI resulted in similarly small but
statistically signiﬁcant decreases in the relative binding afﬁnity
for TnT (Fig. 7A).
Neither PKA phosphorylation nor N-terminal truncation altered
the TnT binding afﬁnity of McTnIA117G (Fig 7B). In contrast, N-ter-
minal truncation, but not PKA phosphorylation, resulted in a small
but statistically signiﬁcant decrease in the TnT binding afﬁnity of
McTnIK118C (Fig. 7C).
To directly compare the effects of N-terminal truncation on the
function of cardiac TnI A117G and K118C mutations, a separate set
of binding studies showed that McTnI-NDA117G had higher afﬁnity
for TnT as compared with that of McTnI-ND and McTnI-NDK118C
(Fig. 7D). A117G mutation in intact cardiac TnI had minimum
effect on TnT binding afﬁnity (Fig. 5). Therefore, the result in
Fig. 6. Mutations in the TnT interface helix decreased the binding afﬁnity of cardiac
TnI for TnC at pCa 4. Protein binding experiments showed that (A) A117G and
K118C mutations did not cause any detectable change in the binding afﬁnity of
cardiac TnI for TnC at pCa 9. (B) At pCa 4, K118C mutation caused a signiﬁcant
decrease in the binding afﬁnity of cardiac TnI for TnC while the adjacent mutation
A117G also had a much less but still statistically signiﬁcant effect (⁄P < 0.001,
⁄⁄⁄P < 0.000001). Statistical analyses were done using Fisher test in Two Way
ANOVA with Origin Pro 8 software.
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nal truncation [18] augmented the functional effect of A117G
mutation. In contrast, the signiﬁcant effect of K118C mutation in
intact cardiac TnI on the binding afﬁnity for TnT (Fig. 5) was min-
imized by N-terminal truncation (Fig. 7D). Altogether, the data
demonstrate that the two adjacent single amino acid substitutions
in the TnT interface of cardiac TnI had differential responses to the
modulatory effect of N-terminal modiﬁcations.
2.6. Effects of N-terminal modiﬁcations on the relative binding afﬁnity
of mutant cardiac TnI for TnC in the Ca2+-depleted state
ELISA protein binding assay showed that at pCa 9, PKA phos-
phorylation and N-terminal truncation did not produce any detect-
able change in the binding afﬁnities of wild type cardiac TnI for
TnC at Ca2+-depleted state (Fig. 8A). In contrast, N-terminal trunca-
tion, but not PKA phosphorylation, produced an increase in the rel-
ative binding afﬁnity of McTnIA117G for TnC at pCa 9 (Fig. 8B). N-
terminal truncation of McTnIK118C produced a similar increase in
the binding afﬁnity of McTnIA117G for TnC at pCa 9 while no change
in afﬁnity was detectable upon PKA phosphorylation (Fig. 8C).
To directly compare the effect of N-terminal truncation on the
binding afﬁnities of A117G and K118C mutants of cardiac TnI forTnC in Ca2+-depleted state, a separate set of protein binding assay
showed that McTnI-NDA117G and McTnI-NDK118C both had higher
binding afﬁnity for TnC than that of McTnI-ND at pCa 9 (Fig. 8D).
Since intact wild type and mutant cardiac TnI had similar binding
afﬁnities for TnC at pCa9 (Fig. 6A), the results in Fig. 8D indicate
that N-terminal truncation, but not PKA phosphorylation, aug-
mented the effects of the TnT interface mutations on the relative
binding afﬁnity for TnC in the Ca2+-depleted state.
2.7. Effects of N-terminal modiﬁcations on the relative binding afﬁnity
of mutant cardiac TnI for TnC in the Ca2+-saturated state
ELISA solid phase protein binding assay showed that PKA phos-
phorylation of Ser23/24 in the N-terminal segment or truncation of
the N-terminal extension of cardiac TnI increased the binding afﬁn-
ity of wild type cardiac TnI for TnC at pCa 4 (Fig. 9A). Similar effects
were seen for McTnIA117G at pCa 4, whereas the effect of N-terminal
truncation was more profound than that of PKA phosphorylation
(Fig. 9B). In contrast, N-terminal truncation, but not PKA phosphor-
ylation, produced a signiﬁcant increase in the relative binding
afﬁnity of McTnIK118C for TnC at pCa 4 (Fig. 9C).
To directly compare the effects of N-terminal truncation on the
binding afﬁnities of the A117G and K118C mutants of cardiac TnI
for TnC in Ca2+-saturated state, a separate set of binding assays
showed that in comparison with wild type control, N-terminal
truncation partially reversed the decreased binding afﬁnity of
McTnIK118C for TnC at pCa 4 (Fig. 6B) with no effect (Fig. 9D) on
the less profoundly decreased binding afﬁnity of McTnIA117G for
TnC at pCa 4 (Fig. 6B). The reduced decrease in the afﬁnity of
McTnIK118C for TnC at pCa 4 upon N-terminal truncation indicates
a rescuing effect to minimize the impact of this dominantly nega-
tive mutation [10].
3. Discussion
TnI–TnT interface is a pivotal structure in the troponin complex,
formed by coiled coils of a-helices. To investigate the function of
the TnI–TnT interface, the present study characterized two patho-
genic mutations of single amino acid substitution, A117G and
K118C, in the TnT-interfacing helix of cardiac TnI for their struc-
tural and functional impacts. Summarized in Table 1, the results
contribute to the following insights into the structure–function
relationship of cardiac TnI.
3.1. K118C and A117G single amino acid substitutions produce distinct
conformational alterations
Molecular modeling showed that substitution of Cys for Lys117
in human troponin complex (K118 in mouse) would not disrupt
the overall a-helical structure of TnI that interacts with TnT but
leads to a new hydrogen bond with Ile114 to generate a structural
alteration in the TnI–TnT interface [6]. In our present study,
A117G and K118C mutations both altered the mobility of cardiac
TnI in SDS–PAGE, in which proteins are largely unfolded. A possible
explanation is that altered tertiary structure of protein may affect
the binding of SDS [29]. Although both mutations are single amino
acid substitutions with smaller residues, McTnIK118C exhibits
slower gel mobility whereas McTnIA117G has faster mobility than
wild type control (Fig. 2). The mobility changes may indicate
changes molecular conformation, which affected the binding of
SDS to cardiac TnI.
We previously demonstrated that N-terminal modiﬁcation by
PKA phosphorylation of Ser23/24 or truncation of the N-terminal
extension results in long-range conformational modulations in car-
diac TnI [18]. The effects of McTnIA117G and McTnIK118C mutations
on SDS–gel mobility remained after truncation of the N-terminal
Fig. 7. Effects of N-terminal modiﬁcation on TnT binding afﬁnity of the mutant cardiac TnI. Protein binding assay showed that (A) both PKA phosphorylation and N-terminal
truncation caused small but statistically signiﬁcant decreases in the binding afﬁnity of wild type mouse cardiac TnI for TnT (⁄P < 0.05 as comparing data points in the binding
curves corresponding to TnT concentrations from 1.6  109 M to 2  107 M). (B) PKA phosphorylation or N-terminal truncation did not affect the binding afﬁnity of
McTnIA117G for TnT. (C) N-terminal truncation, but not PKA phosphorylation, caused a small decrease in the binding afﬁnity of McTnIK118C for TnT (⁄P < 0.02). (D) N-terminal
truncation minimized the effect of K118C mutation on TnT binding and increased the binding afﬁnity of A117G mutation for TnT (⁄⁄⁄P < 0.000001). Statistical analyses were
done using Fisher test in Two Way ANOVA with Origin Pro 8 software.
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A117G and K118C mutations on molecular conformation are dom-
inant traits over the N-terminal modiﬁcation-mediated regulatory
effect.
While the K118C mutation caused clear gel mobility change
that may reﬂect tertiary structure changes affecting the binding
of SDS [29], we detect only a small trend of local conformational
change in cTnIK118C mutation using mAb 4B7 and no remote
change was detected with mAb 4H6. Therefore, the gel mobility
change may indicate conformational changes in regions not probed
by the two mAbs. The opposite effects of the two adjacent muta-
tions in the TnT interface of cardiac TnI implicate their distinct
structural impacts, which is worth further investigation in order
to understand the structural and functional role of the TnI–TnT
interface in the troponin complex.
3.2. Monoclonal antibody epitope mapping of conformational effects of
cardiac TnI mutations
Monoclonal antibodies provide conformational probes to detect
alterations in three-dimensional epitope structure and molecular
conformation [30]. Changes in mAb afﬁnity can be quantiﬁed to
detect local and long-range conformational changes in TnI and
TnT as shown in our previous studies [18,24,28,31]. In the presentstudy, ELISA epitope analysis using mAb probe 4B7 recognizing an
epitope in the segment of cardiac TnI interfacing with TnT [18]
detected changes in the local conformation resulting from
McTnIA117G and McTnIK118C mutations (Fig. 3). Consistent with
their distinct effects on SDS–gel mobility, the local conformational
change resulting from McTnIA117G was different from that from
McTnIK118C, evident by the higher afﬁnity of mAb 4B7 to
McTnIA117G than that to McTnIK118C.
Another mAb probe 4H6 recognizing an epitope in the TnC
binding helix 1 of cardiac TnI [18] was employed to examine
remote conformational changes produced by the TnT interface
mutations. 4H6 detected conformational alteration in McTnIA117G
but not in McTnIK118C (Fig. 4). The distinct remote conforma-
tional effects of McTnIA117G and McTnIK118C further support the
observation that the two adjacent mutations in the TnT interface
of cardiac TnI have distinct effects on overall molecular
conformation.
It is worth noting that more quantitative measurements, such
as circular dichroism studies of a-helical contents and ﬂuorescence
reporter-based protein binding assays in solution, may provide
more insights into the structure–function relationship of the car-
diac TnI mutations. The results from our ELISA epitope analysis
and solid phase protein binding studies have laid groundwork for
the future investigations.
Fig. 8. Effect of N-terminal modiﬁcations on the binding afﬁnities of cardiac TnI and mutants for TnC in the Ca2+ depleted state. Protein binding assay showed that (A) PKA
phosphorylation or N-terminal truncation did not result in detectable change in the afﬁnity of wild type mouse cardiac TnI for TnC at pCa 9. (B) N-terminal truncation, but not
PKA phosphorylation, increased the binding afﬁnity of McTnIA117G for TnC at pCa 9 (⁄⁄⁄P < 0.00001). (C) N-terminal truncation caused a similar increase in the binding afﬁnity
of McTnIK118C for TnC at pCa 9 (⁄P < 0.05) whereas PKA phosphorylation had no detectable effect. (D) N-terminal truncation increased the binding afﬁnity of both McTnI-
NDA117G and McTnI-NDK118C for TnC at pCa 9 as compared with wild type control (⁄⁄⁄P < 0.000001). Statistical analyses were performed using Fisher test in Two Way ANOVA
with Origin Pro 8 software.
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with TnT and TnC
In agreement with previously reported lower binding afﬁnity of
the R111C mutation of turkey cardiac TnI for TnT [6], ELISA protein
binding assay showed that K118C mutation decreased the relative
binding afﬁnity of mouse cardiac TnI for TnT, whereas mutation
A117G did not produce a detectable change in TnT binding afﬁnity
(Fig. 5). The distinct effects of K118C and A117G mutations on TnT
binding may be based on their distinct conformational effects and
suggest that the TnI–TnT interactions are not only determined by
the structure at the binding site but also dependent on the overall
molecular conformation.
Our results further showed that McTnIK118C exhibited lower
binding afﬁnity for TnC at pCa 4 as compared to that of wild type
cardiac TnI, whereas McTnIA117G showed less effect (Fig. 6). The
altered binding afﬁnity for TnC due to mutations in TnT interface
structure demonstrates remote functional effects, supporting a role
of the TnI–TnT interface in the overall conformation and allosteric
function of troponin in the regulation of muscle contraction. The
different effects of A117G and K118C on the binding afﬁnity of car-
diac TnI for TnC also support the distinct remote conformational
effects of the two adjacent TnT interface mutations.
Although the two dominantly negative mutations that we have
studied caused relatively mild changes in the binding afﬁnity forthe other subunits of troponin, the TnI–TnT interface structure
plays a pivotal role in transmitting the conformational signals in
the troponin complex initiated from Ca2+-binding to TnC and
weakened binding between TnI and TnT may have an impact on
this signal transduction. Weaker or stronger binding of TnI to
TnC may also alter myoﬁlament Ca2+ sensitivity. The conforma-
tional change detected in McTnIA117G using mAb 4H6 probe spe-
ciﬁc to the TnC binding helix 1 that interacts with the C domain
of TnC could be responsible for the altered afﬁnity of TnI for TnC
since this region is in close vicinity to the TnI–TnT interface where
the A117G mutation is located.
3.4. Effects of the dominantly negative mutations of cardiac TnI are
modulated by N-terminal modiﬁcations
The N-terminal extension of cardiac TnI is an adult heart-spe-
ciﬁc regulatory structure not present in the two skeletal muscle
isoforms of TnI [2,28]. The regulation of the N-terminal extension
can be mediated through two posttranslational modiﬁcations:
Phosphorylation of Ser23/24 by PKA and limited proteolysis. Proteo-
lytic truncation to selectively remove the N-terminal extension of
cardiac TnI in adaption to hemodynamic stress or b-adrenergic
deﬁciency [19–21] and PKA phosphorylation produce similar con-
formational modulations in the region interfacing with TnT and
similar effects on the binding afﬁnities for TnT and TnC [18].
Fig. 9. Effect of N-terminal modiﬁcations on the binding afﬁnity of cardiac TnI and mutants for TnC in the Ca2+-saturated state. Protein binding assay showed that (A) PKA
phosphorylation or N-terminal truncation increased the binding afﬁnity of wild type mouse cardiac TnI for TnC at pCa 4 (⁄⁄⁄P < 0.00001). (B) PKA phosphorylation increased
the binding afﬁnity of McTnIA117G for TnC at pCa 4 and N-terminal truncation had a more profound effect (⁄⁄P < 0.002, ⁄⁄P < 0.00001). (C) N-terminal truncation, but not PKA
phosphorylation, resulted in signiﬁcantly higher binding afﬁnity of McTnIK118C for TnC at pCa 4 (⁄⁄⁄P < 0.000001). (D) N-terminal truncation decreased the afﬁnity of
McTnIA117G and McTnIK118C for TnC at pCa 4 as compared to the wild type control (⁄⁄P < 0.001). Statistical analyses were done using Fisher test in TwoWay ANOVA with Origin
Pro 8 software.
Table 1
Comparison of the effects of A117G and K118C mutations of cardiac TnI on the interactions with TnT and TnC and the modulation by N-terminal modiﬁcations.
(A) McTnI McTnIA117G (comparing with McTnI) McTnIK118C (comparing with McTnI)
TnT Reference point = ;
TnC (pCa 4) Reference point ; ;
TnC (pCa9) Reference point = =
(B) McTnIPKA (comparing with McTnI) McTnIA117G+PKA (comparing with McTnIA117G) McTnIK118C+PKA (comparing with McTnIK118C)
TnT ; = =
TnC (pCa 4) " " =
TnC (pCa 9) = = =
(C) McTnI-ND (comparing with McTnI) McTnI-NDA117G (comparing with McTnIA117G) McTnI-NDK118C (comparing with McTnIK118C)
TnT ; = ;
TnC (pCa 4) " " "
TnC (pCa 9) = " "
(D) McTnI (ND/PKA) McTnIA117G (ND/PKA) McTnIK118C (ND/PKA)
TnT = = <1
TnC (pCa 4) = >1 >1
TnC (pCa 9) = >1 >1
(A) McTnIA117G and McTnIK118C are compared for TnT and TnC binding afﬁnities with wild type McTnI control as the reference point. (B) TnT and TnC binding afﬁnities of PKA
phosphorylated wild type McTnI, McTnIA117G and McTnIK118C are compared with non-phosphorylated control as the reference point. (C) TnT and TnC binding afﬁnities of N-
terminal truncated wild type McTnI, McTnIA117G and McTnIK118C are compared with their intact protein control as the reference point. ", increased and ;, decreased afﬁnity in
the comparisons; =no difference. (D) TnT and TnC binding afﬁnities of N-terminal truncated McTnI, McTnIA117G and McTnIK118C are compared with that of PKA phosphor-
ylation (ND/PKA ratio >1 or <1 indicates that N-terminal truncation had larger or smaller effect than that of PKA phosphorylation).
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truncation resulted in decreases in the binding afﬁnity of wild type
cardiac TnI for TnT (Fig. 7A). N-terminal truncation, but not PKA
phosphorylation, decreased the binding afﬁnity of McTnIK118C for
TnT (Fig. 7C), whereas neither had detectable effect on the binding
afﬁnity of McTnIA117G for TnT (Fig. 7B). N-terminal truncation res-
cued the decreased afﬁnity of McTnIK118C for TnT (Fig. 7D). While
McTnIA117G had only minimal effect on the afﬁnity for TnT (Fig. 5),
N-terminal truncation increased its TnT binding afﬁnity as com-
pared to the effect on wild type McTnI (Fig. 7D). Altogether, the
results indicate that the conformational effect of N-terminal trun-
cation [18] is able to modulate the function of TnI–TnT interface.
In the calcium depleted state at pCa 9, the binding afﬁnity of
cardiac TnI and the mutants for TnC was low in our ELISA solid
phase protein binding experiments, consistent with that estab-
lished in previous studies [32]. N-terminal truncation, but not
PKA phosphorylation, increased the binding afﬁnity of McTnIA117G
for TnC at pCa 9 (Fig. 8B). N-terminal truncation similarly increased
the binding afﬁnity of McTnIK118C for TnC at pCa 9 while phosphor-
ylation had no detectable effect (Fig. 8C). Although the TnC binding
afﬁnities of intact cardiac TnI and the mutants were similar at pCa
9 (Fig. 6), N-terminal truncation produced detectably higher TnC
binding afﬁnities of McTnI-NDA117G and McTnI-NDK118C at pCa 9
than that produced in wild type cardiac TnI (Fig. 8D). The results
indicate that N-terminal truncation, but not PKA phosphorylation,
selectively affects the function of the mutant, but not wild type
cardiac TnI.
High afﬁnity binding of cardiac TnI and TnC was demonstrated
at pCa 4 in our ELISA solid phase binding assays, also consistent
with that established in previous studies [32]. N-terminal trunca-
tion or PKA phosphorylation increased the binding afﬁnity of wild
type cardiac TnI for TnC at pCa 4 (Fig. 9A). The N-terminal modiﬁ-
cations produced similar responses in McTnIA117G at pCa 4, in
which N-terminal truncation had a more potent effect (Fig. 9B).
In contrast, only N-terminal truncation but not PKA phosphoryla-
tion, increased the afﬁnity of McTnIK118C for TnC at pCa 4
(Fig. 9C). At pCa 4, N-terminal truncation partially corrected the
decreased TnC-binding afﬁnity of McTnIK118C but did not change
the weaker effect of McTnIA117G (Fig. 6B versus Fig. 9D).
Together with the TnT binding studies, the similar but yet dis-
tinct modulatory effects of PKA phosphorylation and N-terminal
truncation on the functional impact of the A117G and K118Cmuta-
tions indicate that these two N-terminal regulatory modiﬁcations
of cardiac TnI have distinct effects on the function of the TnI–TnT
interface. It is worth further investigating the use of N-terminal
modiﬁcations, especially N-terminal truncation, to reduce myo-
pathic impact of TnI–TnT interface mutations.
3.5. Proposed mechanistic insights
In McTnIA117G (A116G in human) a hydrogen in Gly replaced the
methyl group in Ala side chain in wild type McTnI to slightly
decrease the molecular mass without changing charge (10.39 at
pH 7) or isoelectric point (9.57). The conservative minimal change
in physical property is in agreement with the data that although
A117Gmutation altered the local conformation in the TnT interfac-
ing helix of cardiac TnI and caused a remote conformational mod-
ulation in the TnC binding helix 1, it did not alter the binding
afﬁnity for TnT and only slightly reduced the binding afﬁnity for
TnC at pCa 4. Nonetheless, patients with A116G mutation in car-
diac TnI exhibited dilated cardiomyopathy, indicating the func-
tional importance of the TnI–TnT interface that is highly sensitive
to structural alterations.
On the other hand, in McTnIK118C neutral side chain of Cys
replaces positively charged side chain of Lys to cause an acidic shift
of charge of McTnIK118C (9.36 vs 10.39 at pH 7) along with a changein isoelectric point (from 9.57 to 9.42), which is a larger change
than that in McTnIA117G. Molecular modeling previously showed
that substitution of Cys for Lys at this position does not result in
signiﬁcant change in the local structure [6], which supports our
observation of the small conformational change detected using
mAb 4B7 probe. The modeling of the K117C mutation further pre-
dicted an additional hydrogen bond between Cys117 and Ile114.
Therefore, alteration in side chain interactions in the TnT interface
helix may alter the overall conformation of McTnIK118C to cause
functional changes.
In summary, the present study of two adjacent pathogenic
mutations of cardiac TnI provides evidence for a critical role of
the TnI–TnT interface in the function of troponin. While more
investigation is needed to relate these ﬁndings to the development
of cardiomyopathy, alterations in calcium-sensitivity or the
dynamics of calcium activation within the troponin complex might
underlie the mechanisms for the TnI–TnT interface mutations to
cause contractile dysfunction. These protein level phenotypes laid
groundwork for further studies of the pathogenesis and differences
of these mutations in higher order experimental systems, such as
muscle strips and transgenic mouse hearts.4. Materials and methods
4.1. Construction of expression vectors encoding A117G and K118C
mutants of mouse cardiac TnI
A cDNA encoding the K118C mutant of mouse cardiac TnI
(McTnIK118C) was ampliﬁed using polymerase chain reaction
(PCR) from a transgene construct described previously [22]. The
ampliﬁed cDNA was cut with restriction enzymes NdeI and XhoI
and ligated to compatibly cut pAED4 plasmid vector [33].
A cDNA encoding the A117G mutant of mouse cardiac TnI
(McTnIA117G, equivalent to the A116G mutation in human cardiac
TnI) was de novo constructed with synthetic PCR primers and
GENEART site-directed mutagenesis kit (Invitrogen) using the
pAED4 McTnIK118C expression plasmid as template.
The recombinant plasmid DNA was puriﬁed and sequenced to
verify the constructions.
4.2. Construction of expression vectors encoding mutants of N-
terminal truncated mouse cardiac TnI
As described previously for the construction of N-terminal trun-
catedmouse cardiac TnI with the deletion of amino acids 1–28 [22],
recombinant PCR was applied to generate cDNAs encoding N-ter-
minal truncated McTnIA117G and McTnIK118C (Fig. 1B). Using
McTnIA117G and McTnIK118C recombinant pAED4 plasmids as tem-
plates, a forward primer (50-CAACCATATGGCCTATGCCACCGA-30)
containing an NdeI restriction enzyme site (underlined) and an
added Met initiation codon was used together with the 30 ﬂanking
T7 primer in PCR to produce N-terminal truncated cDNA templates.
The ampliﬁed cDNA was digested with NdeI and XhoI and ligated to
compatibly cut pAED4 vector. Recombinant plasmid DNAs encod-
ing N-terminal truncated McTnIA117G (McTnI-NDA117G) and
McTnIK118C (McTnI-NDK118C) were sequenced to verify the
constructions.
4.3. SDS–polyacrylamide gel electrophoresis (PAGE) and Western
blotting
Protein samples of wild type, A117G, and K118C mouse cardiac
TnI, intact and N-terminal truncated, were dissolved in SDS–gel
sample buffer containing 2% SDS and 150 mM DTT for electropho-
resis on SDS–gel (14% gel with acrylamide/bisacrylamide ratio of
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stained with Coomassie Blue R250 to visualize the resolved protein
bands.
Duplicate gels were electrophoretically transferred to nitrocel-
lulose membranes for Western blot analysis. After blocking in 1%
bovine serum albumin (BSA), the membranes were incubated with
an anti-TnI monoclonal antibody (mAb) TnI-1 [34] at 4 C over-
night. The blots were washed with Tris-buffered saline containing
0.5% triton X-100 and 0.05% SDS, further incubated with alkaline
phosphatase-labeled second antibody (Santa Cruz), followed by
ﬁnal washes and 5-bromo-4-chloro-3-indolylphosphate/nitro blue
tetrazolium substrate reaction.
4.4. Expression and puriﬁcation of intact cardiac TnI and mutants
Competent BL21(DE3)pLysS E. coli cells were transformed with
recombinant pAED4 plasmids encoding wild type mouse cardiac
TnI (McTnI), McTnIA117G and McTnIK118C and cultured in 2X TY
media containing carbenicillin (50 lg/mL) and chloramphenicol
(12.5 lg/mL) at 37 C with vigorous shaking. Isopropyl-1-thiol-b-
galactoside (IPTG) was added when O.D.600 of the culture reached
0.3 to induce the expression of recombinant protein. Three hours
after induction, the bacterial cells were harvested by centrifugation
and re-suspended in 50 mM Tris–HCl, pH 8.0, 5 mM EDTA, 15 mM
b-mercaptoethanol and 1 mM phenylmethylsulfonyl ﬂuoride
(PMSF). The cells were lysed by passing through a French press
for three or more times.
After centrifugation to clarify the cell lysate, the supernatant
was fractionated with ammonium sulfate precipitation at 0 C.
The fractions were dialyzed at 4 C against 10 mM citrate buffer,
pH 6.0, containing 0.1 mM EDTA and examined together with the
total lysate using SDS–PAGE and Western blot to determine the
fraction enriched with the recombinant mouse cardiac TnI. The
fraction between 30% and 50% saturation containing the highest
amount of mouse cardiac TnI was added with urea to a ﬁnal con-
centration of 6 M, b-mercaptoethanol to 15 mM and PMSF to
0.5 mM. Centrifuged at high speed to remove any insoluble mate-
rials, the supernatant was loaded to a CM52 cation exchange col-
umn equilibrated at 4 C in the same buffer. Following washing
with the equilibration buffer, the bound protein was eluted with
0–500 mM linear gradient of KCl.
Protein peaks of the CM52 column fractions with A280 absor-
bance were analyzed by SDS–PAGE and Western blot to identify
fractions that contained cardiac TnI or mutants. After dialysis at
4 C against 0.1 mM EDTA and concentrated by lyophilization,
the positive fraction was further fractionated at 4 C on a Sephadex
G75 gel ﬁltration column in 6 M urea, 0.5 M KCl, 0.1 mM EDTA,
6 mM b-mercaptoethanol, and 10 mM imidazole, pH 7.0, as
described previously [6]. The G75 fractions containing puriﬁed
McTnI, McTnIA117G and McTnIK118C were identiﬁed using SDS–
PAGE and veriﬁed with Western blot, dialyzed against 2% formic
acid, and lyophilized.
4.5. Expression and puriﬁcation of N-terminal truncated cardiac TnI
and mutants
The transformation and culture of bacteria for the expression of
N-terminal truncated wild type mouse cardiac TnI (McTnI-ND),
McTnI-NDA117G and McTnI-NDK118C were same as that for the
intact cardiac TnI. McTnI-ND, McTnI-NDA117G and McTnI-NDK118C
expressed in BL21(DE3)pLysS cells formed inclusion bodies that
were collected from cell lysate with centrifugation. Washed with
50 mM Tris–HCl, 5 mM EDTA, pH 8.0, and again with 10 mM cit-
rate, 0.1 mM EDTA, the inclusion bodies were dissolved in ice-cold
6 M urea in 10 mM citrate, 0.1 mM EDTA, 15 mM b-mercap-
toethanol and 0.5 mM PMSF, pH 6.0. The protein extract wascentrifuged at high speed and the supernatant was loaded on a
CM52 column equilibrated at 4 C in the same buffer. The rest of
the puriﬁcation procedure was the same as described for the intact
mouse cardiac TnI and mutants.
4.6. Other myoﬁlament proteins
Bovine cardiac TnT was puriﬁed from adult left ventricular mus-
cle as described previously [35]. Bovine and mouse cardiac TnTs
have very high degree of similarity in amino acid sequence, espe-
cially in the TnI interface helix. Therefore, we used bovine instead
of mouse cardiac TnT in binding studies with mouse cardiac TnI
and mutants.
Chicken fast TnC was puriﬁed from E. coli expression as
described previously [36]. The main difference between cardiac/
slow TnC and fast TnC is in the N domain, in which the metal bind-
ing site I is inactive in cardiac/slow TnC. The two TnC isoforms have
very similar structures in the C domain that binds TnI near the TnI–
TnT interface. For our study of the effect of the two cardiac TnI
mutations on the binding afﬁnity for TnC, the use of fast TnC
instead of cardiac/slow TnC should not cause qualitative
discrepancies.
4.7. Epitope analysis of conformational changes in mutant cardiac TnI
The binding of a protein antigen and a speciﬁc antibody is a pro-
tein–protein interaction based on conformational ﬁt between
three-dimensional structures at the antigenic epitope and the anti-
body paratope. Therefore, mAbs that recognize speciﬁc epitopes
can be utilized as site-speciﬁc structural probes to detect and mon-
itor changes in local structure as well as in overall molecular con-
formation of a protein [28,31]. As described previously, we applied
mAb probes recognizing speciﬁc regions of cardiac TnI in microti-
ter plate enzyme linked immunosorbent assay (ELISA)
[18,31,36,37] to investigate the conformational effects of the TnT
interface mutations in cardiac TnI under native conditions [28,31].
McTnI, McTnIA117G or McTnIK118C proteins was dissolved in
100 mM KCl, 3 mM MgCl2, 20 mM PIPES, pH 7.0 (Buffer A) as
1 lg/mL for coating on 96-well microtiter plates (Immulon 2HB,
Thermo Scientiﬁc) at 100 ll/well at 4 C overnight. The similar
coating of McTnI, McTnIA117G and McTnIK118C on ELISA plate was
veriﬁed by direct titration using TnI-1 mAb that has same afﬁnity
for the three protein variants (data not shown).
Following washes with Buffer A containing 0.05% Tween-20
(Buffer T) to remove unbound protein and block the remaining
plastic surface, the wells were incubated with serial dilutions of
anti-TnI mAbs TnI-1, 4H6 [31], or 4B7 [31] in Buffer A containing
0.1% BSA (Buffer B) at room temperature for 2 h. Washed with Buf-
fer T to remove unbound antibody, the plates were further incu-
bated with horseradish peroxidase (HRP)-conjugated anti-mouse
IgG second antibody (Santa Cruz) in Buffer B. After washes to
remove the unbound second antibody, the plates were developed
with H2O2-ABTS (2-20-azinobis-(3-ethylbenzthiazolinesulfonic
acid) substrate in 0.1 M citrate buffer, pH 4.0. A415nm of each assay
well was monitored with an automated microplate reader (BioRad
Benchmark). Data within the linear course of the color develop-
ment were used to plot the titration curves. All data points were
obtained as the average of triplicate wells and each assay was
repeated three times.
4.8. Phosphorylation of recombinant mouse cardiac TnI and mutants
Puriﬁed recombinant McTnI, McTnIA117G and McTnIK118C
(160 lg/mL) were incubated with 25 lg/mL rabbit skeletal muscle
cAMP-dependent PKA (Sigma Chemical Co.) in a buffer containing
0.1 M NaCl, 10 mM MgCl2, 1 mM DTT, 2 mM ATP, 0.1 mM cAMP,
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was frozen at 80 C to terminate the reaction. PKA-catalyzed
phosphorylation of McTnI, McTnIA117G and McTnIK118C was visual-
ized with Pro-Q Diamond (Invitrogen) staining of SDS–PAGE gel
and quantiﬁed using ImageJ software. The same gel or a parallel
gel was stained with Coomassie Brilliant Blue R250 to determine
the amount of total cardiac TnI in the samples. PeppermintStick
phosphoprotein markers (Invitrogen) were run in the SDS–PAGE
along with the PKA-treated McTnI, McTnIA117G and McTnIK118C
samples as control.
4.9. Solid phase protein binding assay
ELISA solid phase protein binding assay was carried out as
described for binary protein binding studies [6,18,36]. Wild type
or mutant cardiac TnI, intact, N-terminal truncated or PKA phos-
phorylated, was dissolved in Buffer A containing 1 mM DTT at
2.5 lg/mL for coating on microtiter plate at 100 ll/well. After
removal of excess protein by washing with Buffer T containing
1 mM DTT, the wells were blocked with Buffer T containing 1%
BSA and 1 mM DTT at room temperature for 1 h. Following
washes with Buffer T containing 1 mM DTT, the wells were incu-
bated with serial dilutions of bovine cardiac TnT in Buffer B con-
taining 1 mM DTT at room temperature for 2 h. The plates were
then washed with Buffer T to remove unbound TnT and DTT,
incubated with an anti-TnT mAb CT3 [38] at room temperature
for 1 h. The plates were washed again and further incubated
with HRP-conjugated anti-mouse immunoglobulin secondary
antibody at room temperature for 45 min. After washes to
remove excess secondary antibody, substrate reaction and
A415nm recording were carried out as described above in the
ELISA epitope studies.
In TnC binding experiments, microtiter plates coated with var-
ious cardiac TnI proteins were incubated with chicken fast TnC in
Buffer B containing 1 mM DTT, 5 mM EGTA, 5 mM CaCl2 (pCa 4)
or 11 lM CaCl2 (pCa 9). The binding of TnC to immobilized TnI
was detected using an anti-TnC mAb 2C3 [36]. The blocking, wash-
ing and antibody dilution buffers were maintained at either pCa 4
or pCa 9.
Data within the linear course of the color development were
used to plot the binding curves. All data points were obtained as
the average of triplicate wells and each assay was repeated three
times.
The solid phase protein binding assay involves two phases: The
initial binding step reaches equilibrium binding of the protein in
solution to the immobilized protein; and the subsequent washing
separation depends on the coupling strength of the binding in a
non-equilibrium manner [25]. Therefore, we used the concentra-
tion of the protein in solution, which reached 50% maximum bind-
ing together with curve shape to evaluate relative binding afﬁnities
to compare the binding between TnI and other troponin subunits.
4.10. Data analysis
Protein concentrations were determined using Bradford assay
and veriﬁed by quantiﬁcation of TnI protein bands in Coomassie
Blue-stained SDS-gels using ImageJ software. Similar coating of
McTnI, McTnIA117G and McTnIK118C on ELISA plate for binding assay
was veriﬁed by titration with TnI-1 mAb that has identical afﬁnity
for McTnI, McTnIA117G and McTnIK118C (data not shown). Absor-
bance of triplicate ELISA wells was used for analysis. All quantita-
tive data are presented as mean ± SD. Statistical analyses were
performed using Fisher test in Two Way ANOVA with Origin Pro
8 software.Author contribution statement
S.A. designed and carried out the experiments, drafted the paper
and ﬁgures, edited the text and ﬁgures, and approved the submis-
sion. J.P.J. conceived the research, designed the experiments, edited
the paper and ﬁgures, and approved the submission.
Acknowledgments
We thank Hui Wang for technical assistance. This study was
supported by grants from the National Institutes of Health
(AR048816 and HL098945) and a Multidisciplinary Incubator
Grant from the Wayne State University Ofﬁce of Vice President
for Research (to J.-P. Jin).
References
[1] Gordon, A.M., Homsher, E. and Regnier, M. (2000) Regulation of contraction in
striated muscle. Physiol. Rev. 80, 853–924.
[2] Perry, S.V. (1999) Troponin I: inhibitor and facilitator. Mol. Cell. Biochem. 190,
9–32.
[3] Takeda, S., Yamashita, A., Maeda, K. and Maeda, Y. (2003) Structure of the core
domain of human cardiac troponin in the Ca2+-saturated form. Nature 424,
35–41.
[4] Perry, S.V. (1998) Troponin T: genetics, properties and function. J. Muscle Res.
Cell Motil. 19, 575–602.
[5] Takeda, S. (2005) Crystal structure of troponin and the molecular mechanism
of muscle regulation. J. Electron Microsc. 54, 35–41.
[6] Biesiadecki, B.J., Schneider, K.L., Yu, Z.B., Chong, S.M. and Jin, J.P. (2004) An
R111C polymorphism in wild turkey cardiac troponin I accompanying the
dilated cardiomyopathy-related abnormal splicing variant of cardiac troponin
T with potentially compensatory effects. J. Biol. Chem. 279, 13825–13832.
[7] Jin, J.P., Zhang, Z. and Bautista, J.A. (2008) Isoform diversity, regulation, and
functional adaptation of troponin and calponin. Crit. Rev. Gene Expr. 18, 93–
124.
[8] Stefancsik, B., Jha, P.K. and Sarkar, S. (1998) Identiﬁcation and mutagenesis of a
highly conserved domain in troponin T responsible for troponin I binding:
potential role for coiled coil interaction. Proc. Natl. Acad. Sci. U.S.A. 95, 957–962.
[9] Millat, G., Bouvagnet, P., Chevalier, P., Sebbag, L., Dulac, A., Dauphin, C., Jouk,
P.S., Delrue, M.A., Thambo, J., Le Metayer, P., Seronde, M.F., Faivre, L., Eicher, J.C.
and Rousson, R. (2011) Clinical and mutational spectrum in a cohort of 105
unrelated patients with dilated cardiomyopathy. Eur. J. Med. Genet. 54, e570–
e575.
[10] Wei, B., Gao, J., Huang, X.P. and Jin, J.P. (2010) Mutual rescues between two
dominant negative mutations in cardiac troponin I and cardiac troponin T. J.
Biol. Chem. 285, 27806–27816.
[11] Wei, H. and Jin, J.P. (2014) A dominantly negative mutation in cardiac troponin
I at the interface with troponin T causes early remodeling in ventricular
cardiomyocytes. Am. J. Physiol. Cell Physiol. 307, C338–C348.
[12] Solaro, R.J., Rosevear, P. and Kobayashi, T. (2008) The unique functions of
cardiac troponin I in the control of cardiac muscle contraction and relaxation.
Biochem. Biophys. Res. Commun. 369, 82–87.
[13] Hastings, K.E. (1997) Molecular evolution of the vertebrate troponin I gene
family. Cell Struct. Funct. 22, 205–211.
[14] Solaro, R.J. and van der Velden, J. (2010) Why does troponin I have so many
phosphorylation sites? Fact and fancy. J. Mol. Cell. Cardiol. 48, 810–816.
[15] Howarth, J.W., Meller, J., Solaro, R.J., Trewhella, J. and Rosevear, P.R. (2007)
Phosphorylation-dependent conformational transition of the cardiac speciﬁc
N-extension of troponin I in cardiac troponin. J. Mol. Biol. 373, 706–722.
[16] Solaro, R.J. and Kobayashi, T. (2011) Protein phosphorylation and signal
transduction in cardiac thin ﬁlaments. J. Biol. Chem. 286, 9935–9940.
[17] Rao, V.S., Korte, F.S., Razumova, M.V., Feest, E.R., Hsu, H., Irving, T.C., Regnier,
M. and Martyn, D.A. (2012) N- terminal phosphorylation of cardiac troponin I
reduces length dependent calcium sensitivity of contraction in cardiac muscle.
J. Physiol. 591, 475–490.
[18] Akhter, S., Zhang, Z. and Jin, J.P. (2012) The heart speciﬁc NH2 terminal
extension regulates the molecular conformation and function of cardiac
troponin I. Am. J. Physiol. Heart Circ. Physiol. 302, H923–H933.
[19] Feng, H.Z., Chen, M., Weinstein, L.S. and Jin, J.P. (2008) Removal of the N-
terminal extension of cardiac troponin I as a functional compensation for
impaired myocardial beta-adrenergic signaling. J. Biol. Chem. 283, 33384–
33393.
[20] McConnell, B.K., Popovic, Z., Mal, N., Lee, K., Bautista, J., Forudi, F.,
Schwartzman, R., Jin, J.P., Penn, M. and Bond, M. (2009) Disruption of
protein kinase A interaction with A-kinase anchoring proteins in the heart
in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and
troponin I proteolysis. J. Biol. Chem. 284, 1583–1592.
[21] Yu, Z.B., Zhang, L.F. and Jin, J.P. (2001) A proteolytic NH2 terminal truncation of
cardiac troponin I that is up-regulated in simulated microgravity. J. Biol.
Chem. 276, 15753–15760.
S. Akhter, J.-P. Jin / FEBS Open Bio 5 (2015) 64–75 75[22] Barbato, J.C., Huang, Q.Q., Hossain, M.M., Bond, M. and Jin, J.P. (2005)
Proteolytic N-terminal truncation of cardiac troponin I enhances ventricular
diastolic function. J. Biol. Chem. 280, 6602–6609.
[23] Kentish, J.C., McCloskey, D.T., Layland, J., Palmer, S., Leiden, J.M., Martin, A.F.
and Solaro, R.J. (2001) Phosphorylation of troponin I by protein kinase A
accelerates relaxation and crossbridge cycle kinetics in mouse ventricular
muscle. Circ. Res. 88, 1059–1065.
[24] Akhter, S., Bueltmann, K., Huang, X. and Jin, J.P. (2014) Restrictive
cardiomyopathy mutations demonstrate functions of the C-terminal end
segment of troponin I. Arch. Biochem. Biophys. 552–553, 3–10.
[25] Biesiadecki, B.J. and Jin, J.P. (2011) A high throughput solid phase microplate
protein binding assay to investigate interactions between myoﬁlament
proteins. J. Biomed. Biotechnol. 2011, 1–8.
[26] Ingraham, R.H. and Swenson, C.A. (1984) Binary interactions of troponin
subunits. J. Biol. Chem. 259, 9544–9548.
[27] Ngai, S.M., Pearlstone, J.R., Farah, C.S., Reinach, F.C., Smillie, L.B. and Hodges,
R.S. (2001) Structural and functional studies in troponin I and troponin C
interactions. J. Cell. Biochem. 83, 33–46.
[28] Chong, S.M. and Jin, J.P. (2009) To investigate protein evolution by detecting
suppressed epitope structures. J. Mol. Evol. 68, 448–460.
[29] Rath, A., Glibowicka, M., Nadeau, V.G., Chen, G. and Deber, C.M. (2009)
Detergent binding explains anomalous SDS–PAGE migration of membrane
proteins. Proc. Natl. Acad. Sci. U.S.A. 106, 1760–1765.
[30] Goldberg, M.E. (1991) Investigating protein conformation, dynamics and
folding with monoclonal antibodies. Trends Biochem. Sci. 16, 358–362.[31] Wang, J. and Jin, J.P. (1998) Conformational modulation of troponin T by
conﬁguration of the NH2-terminal variable region and functional effects.
Biochemistry 37, 14519–14528.
[32] Farah, C.S., Miyamoto, C.A., Ramos, C.H., da Silva, A.C., Quaggio, R.B., Fujimori,
K., Smillie, L.B. and Reinach, F.C. (1994) Structural and regulatory functions of
the NH2- and COOH-terminal regions skeletal muscle troponin I. J. Biol. Chem.
269, 5230–5240.
[33] Jin, J.P. (1995) Cloned rat cardiac titin class I and class II motifs: expression,
puriﬁcation, characterization, and interaction with F-actin. J. Biol. Chem. 270,
6908–6916.
[34] Jin, J.P., Yang, F.W., Yu, Z.B., Ruse, C.I., Bond, M. and Chen, A. (2001) The highly
conserved COOH terminus of troponin I forms a Ca2+ modulated allosteric
domain in the troponin complex. Biochemistry 40, 2623–2631.
[35] Jin, J.P. and Lin, J.J. (1988) Rapid puriﬁcation of mammalian cardiac troponin T
and its isoform switching in rat hearts during development. J. Biol. Chem. 263,
7309–7315.
[36] Jin, J.P., Chong, S.M. and Hossain, M.M. (2007) Microtiter plate monoclonal
antibody epitope analysis of Ca2+ and Mg2+-induced conformational changes
in troponin C. Arch. Biochem. Biophys. 466, 1–7.
[37] Jin, J.P., Walsh, M.P., Sutherland, C. and Chen, W. (2000) A role for serine-175
in modulating the molecular conformation of calponin. Biochem. J. 350, 579–
588.
[38] Jin, J.P., Chen, A., Ogut, O. and Huang, Q.Q. (2000) Conformational modulation
of slow skeletal muscle troponin T by an NH(2)-terminal metal-binding
extension. Am. J. Physiol. Cell Physiol. 279, C1067–1077.
